24
Views
9
CrossRef citations to date
0
Altmetric
Articles

Aztreonam/Clavulanic Acid in the Treatment of Serious Infections Caused by Stenotrophomonas maltophilia in Neutropenic Patients: Case Reports

Pages 238-240 | Published online: 18 Jul 2013

REFERENCES

  • Robin T, Janda JM. Pseudo-, Xantho-, Stenotrophomonas maltophilia: an emerging pathogen in search of a genus. Clin Microbiol Newslett 1996; 18: 9–12.
  • Bush KG, Jacoby GA, Medeiros AA. A functional clas-sification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211–1233.
  • Garcia-Rodriguez JA, Garcia Sanchez JE, Munoz Bellido JL, Garcia Sanchez E, Garcia Garcia MI. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas mal-tophilia. J Chemother 1991; 3: 143–146.
  • Garcìa-Rodrìguez JA, Garcia Sanchez JE, Garcia Garcia MI, Garcia Sanchez E, Munoz BeIlido JL. Antibiotic suscepti-bility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations. Diagn Microbiol Infect Dis 1991; 14: 239–243.
  • Garcìa-Rodrìguez JA, Garcia Sanchez JE, Munoz BeIlido JL, Garcia Garcia MI, Garcia Sanchez E. Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia. J Antimicrob Chemother 1991; 27: 552–554.
  • Gaìcia-Rodrìguez JA, Garcia Sanchez JE, Munoz BeIlido JL, Garcia Sanchez E, Garcia Garcia MI, Fresnadillo MJ. Rapid diagnosis of Xanthomonas maltophilia. Rev Esp Quimioterap 1991; 4: 333–335.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.